Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo

被引:35
|
作者
Katunuma, N [1 ]
Matsui, A
Inubushi, T
Murata, E
Kakegawa, H
Ohba, Y
Turk, D
Turk, V
Tada, Y
Asao, T
机构
[1] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima 7708514, Japan
[2] Inst Taiho Pharmaceut Co, Hanno, Japan
[3] Jozef Stefan Inst, Dept Biochem, Ljubljana, Slovenia
[4] Univ Tokushima, Sch Dent, Dept Orthodont, Tokushima 770, Japan
关键词
vitamin B-6; cathepsin K; cathepsin S; pyridoxal derivatives; pyridoxal phosphate;
D O I
10.1006/bbrc.1999.1953
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We found that pyridoxal phosphate shows considerable inhibition of cathepsins. CLIK-071, in which the phosphate ester of position 3 of pyridoxal phosphate was replaced by propionate, strongly inhibited cathepsin B. Three new types of synthetic pyridoxal propionate derivatives showing specific inhibition of cathepsin K were developed. New synthetic pyridoxal propionate derivatives, -162, -163, and -164, in which the methyl arm of position 6 of CLIK-071 was additionally modified, strongly inhibited cathepsin K and cathepsin S weakly, but other cathepsins were not inhibited. CLIK-166, in which the position 4 aldehyde of CLIK-071 is replaced by a vinyl radical and position 5 is additionally modified, showed cathepsin K-specific inhibition at 10(-5) M. Pit formation due to bone collagen degradation by cathepsin K of rat osteoclasts was specifically suppressed by administration of CLIK-164, but not by inhibitors of cathepsin L or B. (C) 2000 Academic Press.
引用
收藏
页码:850 / 854
页数:5
相关论文
共 50 条
  • [1] Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo
    Katunuma, N
    Murata, E
    Kakegawa, H
    Matsui, A
    Tsuzuki, H
    Tsuge, H
    Turk, D
    Turk, V
    Fukushima, M
    Tada, Y
    Asao, T
    FEBS LETTERS, 1999, 458 (01) : 6 - 10
  • [2] Development of Cathepsin Inhibitors and Structure-Based Design of Cathepsin B-Specific Inhibitor
    Tomoo, Koji
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (07) : 696 - 707
  • [3] Structure-based design of orally bioavailable cathepsin K inhibitors.
    Thompson, SK
    Michaud, E
    Halbert, SM
    Tomaszek, TA
    Tew, DG
    Zhao, BG
    Smith, WW
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    Kurdyla, J
    Jones, CS
    Abdel-Meguid, SS
    Ijames, CF
    DesJarlais, RL
    Salyers, KL
    Smith, BR
    Levy, MA
    Veber, DF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1157 - U1157
  • [4] Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo
    Wang, Yang
    Cheng, Fei Xiong
    Yuan, Xiao Long
    Tang, Wen Jian
    Shi, Jing Bo
    Liao, Chen Zhong
    Liu, Xin Hua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 112 : 231 - 251
  • [5] Structure-based design of non-peptide, carbohydrazide-based cathepsin K inhibitors
    Thompson, SK
    Halbert, SM
    DesJarlais, RL
    Tomaszek, TA
    Levy, MA
    Tew, DG
    Ijames, CF
    Veber, DF
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (04) : 599 - 605
  • [6] Combination of structure-based design and combinatorial chemistry for the development of cathepsin D inhibitors.
    Kick, EK
    Roe, DC
    Skillman, AD
    Liu, GC
    Ewing, TJA
    Sun, YX
    Kuntz, ID
    Ellman, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 67 - ORGN
  • [7] Structure-based design of specific cathepsin inhibitors and their application to protection of bone metastases of cancer cells
    Katunuma, N
    Tsuge, H
    Nukatsuka, M
    Asao, T
    Fukushima, M
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 397 (02) : 305 - 311
  • [8] Structure-based design of cathepsin K inhibitors containing a benzyloxy-substituted benzoyl peptidomimetic
    Thompson, SK
    Smith, WW
    Zhao, BG
    Halbert, SM
    Tomaszek, TA
    Tew, DG
    Levy, MA
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    Kurdyla, J
    Jones, CS
    DesJarlais, RL
    Abdel-Meguid, SS
    Veber, DF
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) : 3923 - 3927
  • [9] Development of New Cathepsin B Inhibitors: Combining Bioisosteric Replacements and Structure-Based Design To Explore the Structure-Activity Relationships of Nitroxoline Derivatives
    Sosic, Izidor
    Mirkovic, Bojana
    Arenz, Katharina
    Stefane, Bogdan
    Kos, Janko
    Gobec, Stanislav
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (02) : 521 - 533
  • [10] Structure-based development of specific inhibitors for individual cathepsins and their medical applications
    Katunuma, Nobuhiko
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2011, 87 (02): : 29 - 39